Get startedLog in
    Picture of Sumitomo Pharma logo

    4506 — Sumitomo Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapValue Trap
    All News

    Brief: Sumitomo Pharma Announces that DSP-5336 Has Received FDA Fast Track Designation for the Treatment of Relapsed

    Picture of Sumitomo Pharma logoSumitomo Pharma
    15/07/2024 14:41
    July 15 (Reuters) - Sumitomo Pharma Co Ltd  4506.T :
    * SUMITOMO PHARMA ANNOUNCES THAT DSP-5336 HAS RECEIVED FDA
FAST
TRACK DESIGNATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY
ACUTE MYELOID LEUKEMIA

Source text for Eikon:  ID:nPn9GtWx0a 
Further company coverage:  4506.T 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sumitomo Pharma

    See all news